Thrombocytopenia after transcatheter valve-in-valve implantation: prognostic marker or mere finding?

Abstract Objective: To analyze the behavior of platelets after transcatheter valve-in-valve implantation for the treatment of degenerated bioprosthesis and how they correlate with adverse events upon follow-up. Methods: Retrospective analysis of 28 patients who received a valve-in-valve implant, 5 in aortic, 18 in mitral and 5 in tricuspid positions. Data were compared with 74 patients submitted to conventional redo valvular replacements during the same period, and both groups' platelet curves were analyzed. Statistical analysis was conducted using the IBM SPSS Statistics(r) 20 for Windows. Results: All patients in the valve-in-valve group developed thrombocytopenia, 25% presenting mild (<150.000/µL), 54% moderate (<100.000/µL) and 21% severe (<50.000/µL) thrombocytopenia. The platelet nadir was on the 4th postoperative day for aortic ViV, 2nd for mitral and 3rd for tricuspid patients, with the majority of patients recovering regular platelet count. However, the aortic subgroup comparison between valve-in-valve and conventional surgery showed a statistically significant difference from the 7th day onwards, where valve-in-valve patients had more severe and longer lasting thrombocytopenia. This, however, did not translate into a higher postoperative risk. In our study population, postoperative thrombocytopenia did not correlate with greater occurrence of adverse outcomes and only normal preoperative platelet count could significantly predict a postoperative drop >50%. Conclusion: Although thrombocytopenia is an extremely common finding after valve-in-valve procedures, the degree of platelet count drop did not correlate with greater incidence of postoperative adverse outcomes in our study population.

A new experimental device for transapical access of the aortic and mitral valves as well as the aorta in its various segments

Abstract Objective: To present the results of a new experimental device developed to facilitate the transapical access in endovascular treatment of structural heart diseases. It aims to reduce the risk of bleeding and complications in this type of access and demonstrate the device as a safe, fast and effective alternative. Methods: CorPoint is composed of three parts: introducer, base with coiled spring, and closing capsule. By rotating movements, the spring is introduced into the myocardium and progressively approaches the base to the surface of the heart. Guidewires and catheters are inserted through the hollow central part and, at the end of the procedure, the capsule is screwed over the base, therefore stopping any bleeding. Results: The device was implanted in 15 pigs, weighing 60 kg each, through an anterolateral thoracotomy, while catheters were introduced and guided by fluoroscopy. All animals had minimal bleeding; introducers with diameter up to 22 Fr were used and various catheters and guidewires were easily handled. After finishing the procedure, the closing capsule was attached and no bleeding was observed at the site. Conclusion: This new device has proved effective, fast and secure for the transapical access. This shows great potential for use, especially by ensuring an easier and direct access to the mitral and aortic valves; the shortest distance to be traveled by catheters; access to the ascending and descending aorta; decreased bleeding complications; decreased surgical time; and the possibility of allowing the technique to evolve and become totally percutaneous.

Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder

Objective: To evaluate serum levels of different biomarkers associated with cardiovascular disease in patients with bipolar disorder (BD). Patients were prospectively evaluated in two separate instances: during acute mania and after remission of manic symptoms. All measurements were compared with those of healthy controls. Methods: The study included 30 patients with BD and 30 healthy controls, matched for gender and age. Biochemical parameters evaluated included homocysteine (Hcy), folic acid, vitamin B12, ferritin, creatine kinase (CK) and C-reactive protein (CRP). Results: Hcy levels were significantly higher in the BD patients, both during mania and after achieving euthymia. When Hcy was adjusted for body mass index, there was no significant difference between patients and controls. Ferritin was the only marker that showed a significant decrease during mania when compared to both euthymic patients and controls. There were no significant differences for folate, vitamin B12, CK and CRP. Conclusions: These findings do not show an association between alterations of markers of cardiovascular risk during manic episodes. Further studies are necessary to determine factors and mechanisms associated with cardiovascular risk in patients with BD. .

Prevalência de sintomas depressivos em uma amostra de prostitutas de Porto Alegre / Prevalence of depressive symptoms in a sample of prostitutes in Porto Alegre

INTRODUÇÃO: a prevalência de transtornos depressivos na população feminina de Porto Alegre é estimada em 14,5 por cento. Não existem relatos sobre a prevalência de sintomas ou transtornos depressivos entre as prostitutas, população de risco para transtornos mentais. OBJETIVOS: quantificar a prevalência de sintomas depressivos em amostra de prostitutas de Porto Alegre e fatores associados. MATERIAL E MÉTODOS: uma amostra consecutiva e não aleatória de 97 mulheres entre 18 e 60 anos, cadastradas na Organização Não Governamental Núcleo de Estudos da Prostituição (NEP), de Porto Alegre, foi estudada. Após consentimento informado, as entrevistadas foram investigadas através do Inventário para depressão de Beck (BDI). O ponto de corte igual ou maior que 13 foi utilizado para detecção de sintomas depressivos. RESULTADOS: na amostra estudada, a idade média foi de 29,6 anos (dp 8,5 anos); 67 por cento apresentaram sintomas depressivos (ponto de corte³ 13) com escore médio no BDI de 19,1 (dp 10,9); 24,7 por cento da amostra apresentava sintomas leves; 40,2 por cento sintomas moderados e 7,2 por cento sintomas graves. Houve associação estatisticamente significativa entre a presença de sintomas depressivos e uso de álcool, história de doenças sexualmente transmissíveis e ausência de prática religiosa (p<0,05). CONCLUSÃO: além de alta taxa de prevalência de sintomas depressivos (67 por cento), 47,4 por cento das mulheres avaliadas apresentaram níveis moderado e grave de sintomatologia. O uso de álcool, história de doenças sexualmente transmissíveis e ausência de prática religiosa surgiram como fatores associados à presença de sintomas depressivos na amostra estudada.